Comparing Immune-Related Adverse Events in Elderly Patients with Gastrointestinal and Lung Cancers
In the evolving landscape of oncology, the surge of immune checkpoint inhibitors (ICIs) has marked a paradigm shift, especially among elderly cancer patients. As the...
















